Unknown

Dataset Information

0

Survival Assessment by Central Review vs. Local Investigator in Metastatic Melanoma: A Systematic Review and Meta-Analysis †

ABSTRACT:

SUBMITTER: Eljilany I 

PROVIDER: S-EPMC12938985 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis.
| S-EPMC6887637 | biostudies-literature
Unknown Survival Outcomes in Sinonasal Mucosal Melanoma: Systematic Review and Meta-Analysis.
| S-EPMC11678336 | biostudies-literature
Unknown Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials.
| S-EPMC4443445 | biostudies-literature
Unknown Impact of initial stage on metastatic melanoma survival.
| S-EPMC7594582 | biostudies-literature
Unknown Treatment-Free Survival After Nivolumab vs Pembrolizumab vs Nivolumab-Ipilimumab for Advanced Melanoma.
| S-EPMC10290253 | biostudies-literature
Unknown Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma.
| S-EPMC5315084 | biostudies-literature
Unknown Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.
| S-EPMC9184262 | biostudies-literature
Unknown Improved survival with ipilimumab in patients with metastatic melanoma.
| S-EPMC3549297 | biostudies-literature
Unknown Long-term relative survival in uveal melanoma: a systematic review and meta-analysis.
| S-EPMC9053233 | biostudies-literature
Unknown Survival after cessation of immunotherapies in melanoma: A systematic review and meta-analysis.
| S-EPMC12553132 | biostudies-literature